Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The ...
MakeMyTrip beat Wall Street's Q1 earnings target, but that's not the only reason the stock is rising today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results